ROIV - Roivant Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$40.00
DETAILS
HIGH:
$42.00
LOW:
$36.00
MEDIAN:
$41.00
CONSENSUS:
$40.00
UPSIDE:
6.44%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 6,271,467 | $221.9M | 0.6% | -380,981 | DECREASED |
| Cooperman | 2,972,702 | $105.2M | 0.1% | +1,579,954 | INCREASED |
| Greenblatt | 1,349,465 | $47.8M | 0.1% | -66,626 | DECREASED |
| Wood | 6,600 | $233,574 | 0.0% | -40,800 | DECREASED |
| Soros | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-20 | Pulik Richard | officer: CFO | F-InKind | 5,749 | $36.84 | $212K |
| 2026-08-20 | Venker Eric | officer: President & Immunovant CEO | F-InKind | 13,909 | $36.84 | $512K |
| 2026-08-19 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 172,899 | $3.85 | $666K |
| 2026-08-19 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 172,899 | $37.17 | $6.4M |
| 2026-08-20 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 17,519 | $37.30 | $653K |
| 2026-08-21 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 144,756 | $3.85 | $557K |
| 2026-08-21 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 144,756 | $36.48 | $5.3M |
| 2026-08-20 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 17,519 | $3.85 | $67K |
| 2026-08-18 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 136,942 | $3.85 | $527K |
| 2026-08-14 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 243,177 | $3.85 | $936K |
| 2026-08-18 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 105,141 | $3.85 | $405K |
| 2026-08-18 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 31,801 | $3.85 | $122K |
| 2026-08-18 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 105,141 | $36.59 | $3.8M |
| 2026-08-14 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 243,177 | $36.23 | $8.8M |
| 2026-08-17 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 284,707 | $36.25 | $10.3M |
| 2026-08-18 | Sukhatme Mayukh | director, officer: President & CIO | SELL | 31,801 | $37.18 | $1.2M |
| 2026-08-17 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 284,707 | $3.85 | $1.1M |
| 2026-07-27 | Venker Eric | officer: President & Immunovant CEO | SELL | 200,000 | $34.95 | $7.0M |
| 2026-07-27 | Venker Eric | officer: President & Immunovant CEO | M-Exempt | 200,000 | $3.85 | $770K |
| 2026-07-17 | Epperly Melissa B, | director | A-Award | 543 | -- | -- |
| 2026-07-17 | Oren Ilan | director | A-Award | 775 | -- | -- |
| 2026-07-17 | MOMTAZEE JAMES C | director | A-Award | 405 | -- | -- |
| 2026-06-30 | Torti Frank | officer: President and Vant Chair | F-InKind | 40,310 | $35.39 | $1.4M |
| 2026-06-30 | Sukhatme Mayukh | director, officer: President & CIO | F-InKind | 46,878 | $35.39 | $1.7M |
| 2026-06-30 | Gline Matthew | director, officer: CEO | F-InKind | 76,171 | $35.39 | $2.7M |